News

New data from a 15-year study presented at the Conference on Retroviruses and Opportunistic Infections (CROI) in San Francisco reveals significant disparities in latent tuberculosis infection (LTBI) testing practices within the United States.

A recent study presented at the Conference on Retroviruses and Opportunistic Infections (CROI) in San Francisco has unveiled a simplified approach to assessing antiretroviral therapy (ART) adherence among pregnant women living with HIV in Malawi.

A recent phase 3 open-label extension study has demonstrated that delgocitinib cream is both safe and effective for long-term management of chronic hand eczema (CHE) in adults.

A recent analysis from the RESOLVE-1 trial has highlighted the potential of mycophenolate mofetil (MMF) in treating diffuse cutaneous systemic sclerosis (dcSSc), particularly in early-stage disease.

A new systematic review and meta-analysis of over 1.3 million patients has confirmed that remdesivir significantly improves survival rates for hospitalized COVID-19 patients, yet treatment guidelines may not fully reflect this evolving evidence.

Increasing diversity in research, from basic science to clinical trials, remains essential for advancing equitable healthcare outcomes.

Financial challenges faced by family surrogate decision-makers of stroke patients were highlighted in a new study that revealed that nearly half experience moderate to severe concerns about affording stroke-related medical expenses.

In a pivotal development for the oncology community, a recent retrospective study has demonstrated that continuing immunotherapy beyond disease progression offers significant survival benefits for patients with advanced non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC).